Click here to go to the previous page
Program Code:
FIN
Time:
12:05 AM to 1:05 AM
FIN010: Creative Financing Options for Development-Stage Companies
FIN020: New Funding Alternatives for the Biotech Industry
FIN030: An Investment Perspective on Drug Discovery
FIN040: Anticipating the Economic Challenges of Personalized Medicine
FIN060: Does Forward Integration Make Financial Sense for Your Biopharmaceutical Company?
FIN070: Funding vs. Value Retention: Can a Small Company Do Both?
FIN080: Strategic Investments in Biotechnology Companies: Structuring Win/Win Transactions
FIN090: The Great Debate: Acquisition or IPO?
FIN100: Financing Strategies for Pharmaceutical Companies: A Combination of Debt, Equity and Royalty Streams